These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32450415)

  • 1. Associations between facial affect recognition and neurocognition in subjects at ultra-high risk for psychosis: A case-control study.
    Randers L; Jepsen JRM; Fagerlund B; Nordholm D; Krakauer K; Hjorthøj C; Glenthøj B; Nordentoft M
    Psychiatry Res; 2020 Aug; 290():112969. PubMed ID: 32450415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurocognitive impairments in individuals at ultra-high risk for psychosis: Who will really convert?
    Bang M; Kim KR; Song YY; Baek S; Lee E; An SK
    Aust N Z J Psychiatry; 2015 May; 49(5):462-70. PubMed ID: 25425742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired facial emotion recognition in individuals at ultra-high risk for psychosis and with first-episode schizophrenia, and their associations with neurocognitive deficits and self-reported schizotypy.
    Lee SY; Bang M; Kim KR; Lee MK; Park JY; Song YY; Kang JI; Lee E; An SK
    Schizophr Res; 2015 Jun; 165(1):60-5. PubMed ID: 25864951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. General intellectual functioning as a buffer against theory-of-mind deficits in individuals at ultra-high risk for psychosis.
    Hur JW; Byun MS; Shin NY; Shin YS; Kim SN; Jang JH; Kwon JS
    Schizophr Res; 2013 Sep; 149(1-3):83-7. PubMed ID: 23810120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurocognitive functioning of subjects with putative pre-psychotic states and early psychosis.
    Liu CC; Hua MS; Hwang TJ; Chiu CY; Liu CM; Hsieh MH; Chien YL; Lin YT; Hwu HG
    Schizophr Res; 2015 May; 164(1-3):40-6. PubMed ID: 25802138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interview and questionnaire assessment of cognitive impairment in subjects at ultra-high risk for psychosis: Associations with cognitive test performance, psychosocial functioning, and positive symptoms.
    Randers L; Fagerlund B; Jepsen JRM; Nordholm D; Krakauer K; Hjorthøj C; Glenthøj B; Nordentoft M
    Psychiatry Res; 2020 Dec; 294():113498. PubMed ID: 33157481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive functioning in individuals at ultra-high risk for psychosis, first-degree relatives of patients with psychosis and patients with first-episode schizophrenia.
    Hou CL; Xiang YT; Wang ZL; Everall I; Tang Y; Yang C; Xu MZ; Correll CU; Jia FJ
    Schizophr Res; 2016 Jul; 174(1-3):71-76. PubMed ID: 27197904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Social cognition in clinical "at risk" for psychosis and first episode psychosis populations.
    Thompson A; Papas A; Bartholomeusz C; Allott K; Amminger GP; Nelson B; Wood S; Yung A
    Schizophr Res; 2012 Nov; 141(2-3):204-9. PubMed ID: 22959742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurocognitive predictors of transition to psychosis: medium- to long-term findings from a sample at ultra-high risk for psychosis.
    Lin A; Yung AR; Nelson B; Brewer WJ; Riley R; Simmons M; Pantelis C; Wood SJ
    Psychol Med; 2013 Nov; 43(11):2349-60. PubMed ID: 23388122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls.
    Korver N; Nieman DH; Becker HE; van de Fliert JR; Dingemans PH; de Haan L; Spiering M; Schmitz N; Linszen DH
    Aust N Z J Psychiatry; 2010 Mar; 44(3):230-6. PubMed ID: 20180725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Social cognition and neurocognition as predictors of conversion to psychosis in individuals at ultra-high risk.
    Kim HS; Shin NY; Jang JH; Kim E; Shim G; Park HY; Hong KS; Kwon JS
    Schizophr Res; 2011 Aug; 130(1-3):170-5. PubMed ID: 21620681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurocognition as a predictor of transition to psychotic disorder and functional outcomes in ultra-high risk participants: Findings from the NEURAPRO randomized clinical trial.
    Bolt LK; Amminger GP; Farhall J; McGorry PD; Nelson B; Markulev C; Yuen HP; Schäfer MR; Mossaheb N; Schlögelhofer M; Smesny S; Hickie IB; Berger GE; Chen EYH; de Haan L; Nieman DH; Nordentoft M; Riecher-Rössler A; Verma S; Thompson A; Yung AR; Allott KA
    Schizophr Res; 2019 Apr; 206():67-74. PubMed ID: 30558978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurocognition and social cognition in youth and young adults at ultra-high-risk for psychosis and bipolar disorder.
    Bora E; Eyuboglu MS; Cesim E; Demir M; Yalincetin B; Ermis C; Özbek Uzman S; Sut E; Demirlek C; Verim B; Baykara B; Akay A; İnal N; Akdede BB
    Schizophr Res; 2024 Apr; 266():58-65. PubMed ID: 38368706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antisaccade task performance in patients at ultra high risk for developing psychosis.
    Nieman D; Becker H; van de Fliert R; Plat N; Bour L; Koelman H; Klaassen M; Dingemans P; Niessen M; Linszen D
    Schizophr Res; 2007 Sep; 95(1-3):54-60. PubMed ID: 17656071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlates of neurocognitive functions in individuals at ultra-high risk for psychosis - A 6-month follow-up study.
    Sanada K; de Azúa SR; Nakajima S; Alberich S; Ugarte A; Zugasti J; Vega P; Martínez-Cengotitabengoa M; González-Pinto A
    Psychiatry Res; 2018 Oct; 268():1-7. PubMed ID: 29986171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive deficits in clinical and familial high risk groups for psychosis are common as in first episode schizophrenia.
    Üçok A; Direk N; Koyuncu A; Keskin-Ergen Y; Yüksel Ç; Güler J; Karadayı G; Akturan E; Devrim-Üçok M
    Schizophr Res; 2013 Dec; 151(1-3):265-9. PubMed ID: 24262680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spatial working memory ability in individuals at ultra high risk for psychosis.
    Goghari VM; Brett C; Tabraham P; Johns L; Valmaggia L; Broome M; Woolley J; Bramon E; Howes O; Byrne M; McGuire P
    J Psychiatr Res; 2014 Mar; 50():100-105. PubMed ID: 24398256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurocognitive predictors of functional outcome two to 13 years after identification as ultra-high risk for psychosis.
    Lin A; Wood SJ; Nelson B; Brewer WJ; Spiliotacopoulos D; Bruxner A; Broussard C; Pantelis C; Yung AR
    Schizophr Res; 2011 Oct; 132(1):1-7. PubMed ID: 21763109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurocognitive and clinical predictors of long-term outcome in adolescents at ultra-high risk for psychosis: a 6-year follow-up.
    Ziermans T; de Wit S; Schothorst P; Sprong M; van Engeland H; Kahn R; Durston S
    PLoS One; 2014; 9(4):e93994. PubMed ID: 24705808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Figural fluency and immediate visual memory in patients with at-risk mental state for psychosis: empirical study.
    Pawełczyk A; Kotlicka-Antczak M; Rabe-Jabłońska J; Pawełczyk T; Ruszpel A; Łojek E
    Early Interv Psychiatry; 2015 Aug; 9(4):324-30. PubMed ID: 24373200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.